drugset / Trial / NCT00467935
Scotoma Reduction in AMD Patients Treated With Ranibizumab
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This is a trial aimed at patients with advanced wet macular degeneration and macular scarring treated wiht intravitreal injections of Lucentis.
Timeline
- Start
- 2007-03
- Primary completion
- 2007-11
- Completion
- 2007-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ranibizumab | Monoclonal antibody | — | Intravitreal |